394 related articles for article (PubMed ID: 20173137)
41. Body Mass Index and Unenhanced CT as a Predictor of Hepatic Steatosis in Potential Liver Donors.
Adalı G; Bozkurt B; Ceyhan Ö; Server S; Doğusoy GB; Yüzer Y; Tokat Y
Transplant Proc; 2019 Sep; 51(7):2373-2378. PubMed ID: 31402250
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of Hepatic Steatosis with CT and Correlation with Anthropometric Measurements.
Taydas O; Koc U
Curr Med Imaging; 2020; 16(4):452-458. PubMed ID: 32410546
[TBL] [Abstract][Full Text] [Related]
43. Predictive Value of Unenhanced Computerized Tomography for Detecting Hepatosteatosis in Living Liver Donors.
Kuzu UB; Gökcan H; Suna N; Özdemir M; Yıldız H; Kaçar S; Turhan N; Ökten S; Bostancı B; Akdoğan M
Transplant Proc; 2015; 47(6):1854-9. PubMed ID: 26293063
[TBL] [Abstract][Full Text] [Related]
44. Detection of moderate hepatic steatosis on contrast-enhanced dual-source dual-energy CT: Role and accuracy of virtual non-contrast CT.
Catania R; Jia L; Haghshomar M; Miller FH; Borhani AA
Eur J Radiol; 2024 Mar; 172():111328. PubMed ID: 38325187
[TBL] [Abstract][Full Text] [Related]
45. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals.
Chhabra R; O'Keefe JH; Patil H; O'Keefe E; Thompson RC; Ansari S; Kennedy KF; Lee LW; Helzberg JH
Mayo Clin Proc; 2013 Nov; 88(11):1259-65. PubMed ID: 24138963
[TBL] [Abstract][Full Text] [Related]
46. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation.
Oliva MR; Mortele KJ; Segatto E; Glickman JN; Erturk SM; Ros PR; Silverman SG
J Comput Assist Tomogr; 2006; 30(1):37-43. PubMed ID: 16365570
[TBL] [Abstract][Full Text] [Related]
47. Visceral adipose tissue area is an independent risk factor for hepatic steatosis.
Park BJ; Kim YJ; Kim DH; Kim W; Jung YJ; Yoon JH; Kim CY; Cho YM; Kim SH; Lee KB; Jang JJ; Lee HS
J Gastroenterol Hepatol; 2008 Jun; 23(6):900-7. PubMed ID: 17995942
[TBL] [Abstract][Full Text] [Related]
48. Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver.
Jawahar A; Gonzalez B; Balasubramanian N; Adams W; Goldberg A
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):216-221. PubMed ID: 31584463
[TBL] [Abstract][Full Text] [Related]
49. The Assessment of Hepatosteatosis in Living-Donor Liver Transplant: Comparison of Liver Attenuation Index and Histopathologic Results.
Sagir Kahraman A; Karakas HM; Kirimlioglu H; Kahraman B; Yilmaz S; Kirimlioglu V
Exp Clin Transplant; 2017 Feb; 15(1):69-77. PubMed ID: 26221870
[TBL] [Abstract][Full Text] [Related]
50. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol.
Kamiyama T; Fukukura Y; Yoneyama T; Takumi K; Nakajo M
Radiology; 2009 Feb; 250(2):474-81. PubMed ID: 19037020
[TBL] [Abstract][Full Text] [Related]
51. CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease.
Kim HN; Jeon HJ; Choi HG; Kwon IS; Rou WS; Lee JE; Lee TH; Kim SH; Lee BS; Shin KS; Lee HJ; Eun HS
BMC Gastroenterol; 2023 Mar; 23(1):77. PubMed ID: 36932382
[TBL] [Abstract][Full Text] [Related]
52. Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard.
Kim DY; Park SH; Lee SS; Kim HJ; Kim SY; Kim MY; Lee Y; Kim TK; Khalili K; Bae MH; Lee JY; Lee SG; Yu ES
Eur Radiol; 2010 Feb; 20(2):359-66. PubMed ID: 19727755
[TBL] [Abstract][Full Text] [Related]
53. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screening.
Chen X; Ma T; Yip R; Perumalswami PV; Branch AD; Lewis S; Crane M; Yankelevitz DF; Henschke CI
Clin Imaging; 2020 Apr; 60(2):237-243. PubMed ID: 31945662
[TBL] [Abstract][Full Text] [Related]
54. Can high-attenuation renal cysts be differentiated from renal cell carcinoma at unenhanced CT?
Jonisch AI; Rubinowitz AN; Mutalik PG; Israel GM
Radiology; 2007 May; 243(2):445-50. PubMed ID: 17456870
[TBL] [Abstract][Full Text] [Related]
55. Quantification of Liver Fat Content With Unenhanced MDCT: Phantom and Clinical Correlation With MRI Proton Density Fat Fraction.
Pickhardt PJ; Graffy PM; Reeder SB; Hernando D; Li K
AJR Am J Roentgenol; 2018 Sep; 211(3):W151-W157. PubMed ID: 30016142
[TBL] [Abstract][Full Text] [Related]
56. [Prevalence and risk factors of hepatic steatosis in patients with chronic hepatitis B].
Shi JP; Fan JG; Wu R; Gao XQ; Zhang L; Wang H
Zhonghua Gan Zang Bing Za Zhi; 2008 Jul; 16(7):519-23. PubMed ID: 18647531
[TBL] [Abstract][Full Text] [Related]
57. Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patients.
Shores NJ; Link K; Fernandez A; Geisinger KR; Davis M; Nguyen T; Sawyer J; Rudel L
Dig Dis Sci; 2011 Jul; 56(7):2145-51. PubMed ID: 21318585
[TBL] [Abstract][Full Text] [Related]
58. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：.
Idilman IS; Akata D; Hazirolan T; Doganay Erdogan B; Aytemir K; Karcaaltincaba M
J Diabetes; 2015 Mar; 7(2):279-86. PubMed ID: 24893617
[TBL] [Abstract][Full Text] [Related]
59. Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods.
Kim JM; Ha SY; Joh JW; Sinn DH; Jeong WK; Choi GS; Gwak GY; Kwon CHD; Kim YK; Paik YH; Lee JH; Lee WJ; Lee SK; Park CK
Medicine (Baltimore); 2016 Feb; 95(7):e2718. PubMed ID: 26886612
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people.
Torgersen J; So-Armah K; Freiberg MS; Goetz MB; Budoff MJ; Lim JK; Taddei T; Butt AA; Rodriguez-Barradas MC; Justice AC; Kostman JR; Lo Re V
BMC Gastroenterol; 2019 Apr; 19(1):52. PubMed ID: 30987601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
